InvestorsHub Logo
Followers 7
Posts 410
Boards Moderated 0
Alias Born 06/04/2014

Re: None

Monday, 03/27/2017 7:06:46 AM

Monday, March 27, 2017 7:06:46 AM

Post# of 21531
In addition to Dr. Alkon's Keynote address at todays Sachs Forum "Neurotrope's Chief Executive Officer Dr. Susanne Wilke PhD, together with Dr. Alkon, will be presenting at 3:00 pm EDT, to discuss the Company's disruptive approach to Alzheimer's disease treatment, current clinical development plan, and upcoming milestones. A live webcast of the presentation will be available online at:
.

Neurotrope's President and Chief Scientific Officer to Present Keynote Address at Sachs Associates' 2nd Annual Neuroscience Biopartnering & Investment Forum


http://www.prnewswire.com/news-releases/neurotropes-president-and-chief-scientific-officer-to-present-keynote-address-at-sachs-associates-2nd-annual-neuroscience-biopartnering--investment-forum-300428998.html




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News